Elsubrutinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Elsubrutinib, covering 2023-07-21 to 2025-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State [Phase 2]